BioRestorative Therapies, Inc. (BRTX) earnings
BRTX earnings moved a median of -1.63% by the close. Quarterly and annual BRTX reports and results, each read against the price at its own news timestamp. Back to the BRTX overview →
28 measured BRTX earnings events.
Where these BRTX earnings landedvs 26 measured BRTX earnings reactions
| Middle 50% of BRTX earnings reactions | -4.57% to +3.20% |
|---|---|
| Median reaction (to close) | -1.63% |
| Measured reactions | 26 |
Point-in-time · zero look-ahead
Half of the 26 BRTX earnings events with a measured close landed between -4.57% and +3.20%; 35% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form NT 10-Q BioRestorative Therapies For: Jun 30 | SEC filing · Form NT | -2.01% | -3.93% | |
| Form 10-Q BioRestorative Therapies For: Mar 31 | SEC filing · Form 10-Q | -0.74% | +1.16% | |
| Form 10-K BioRestorative Therapies For: Dec 31 | SEC filing · Form 10-K | -1.50% | -0.93% | |
| BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | -1.03% | — | |
| Form 10-Q BioRestorative Therapies For: Sep 30 | SEC filing · Form 10-Q | -1.03% | — | |
| BioRestorative Therapies to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025 | Press release | — | -4.11% | |
| BioRestorative Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | +3.67% | +6.38% | |
| Form 10-Q BioRestorative Therapies For: Jun 30 | SEC filing · Form 10-Q | +3.67% | +6.38% | |
| BioRestorative Therapies to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025 | Press release | +0.00% | -1.71% | |
| BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | -2.85% | -4.57% | |
| Form 10-Q BioRestorative Therapies For: Mar 31 | SEC filing · Form 10-Q | -2.85% | -4.57% | |
| BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025 | Press release | — | -1.64% | |
| Form 10-K BioRestorative Therapies For: Dec 31 | SEC filing · Form 10-K | -1.62% | -1.63% | |
| BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update | Press release | -5.62% | -13.48% | |
| Form 10-Q BioRestorative Therapies For: Sep 30 | SEC filing · Form 10-Q | -5.62% | -13.48% | |
| Form 10-K/A BioRestorative Therapies For: Dec 31 | SEC filing · Form 10-K | -2.44% | -4.88% | |
| BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update | Press release | -11.40% | -6.04% | |
| Form 10-Q BioRestorative Therapies For: Jun 30 | SEC filing · Form 10-Q | -11.40% | -6.04% | |
| BioRestorative Therapies to Report Second Quarter 2024 Financial Results and Host Conference Call on August 13, 2024 | Press release | +0.00% | -8.33% | |
| BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results | Press release | +1.08% | +20.00% | |
| Form 10-K/A BioRestorative Therapies For: Dec 31 | SEC filing · Form 10-K | +1.72% | +16.38% | |
| Form 10-Q BioRestorative Therapies For: Mar 31 | SEC filing · Form 10-Q | +1.72% | +16.38% | |
| Form NT 10-Q BioRestorative Therapies For: Mar 31 | SEC filing · Form NT | +1.12% | -2.98% | |
| BioRestorative Therapies Provides First Quarter 2024 Business Update | Press release | -2.89% | -0.72% | |
| BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 | Press release | +1.01% | -0.72% | |
| BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K | Press release | +0.28% | +3.70% | |
| Form 10-K BioRestorative Therapies For: Dec 31 | SEC filing · Form 10-K | +0.28% | +3.70% | |
| Form 10-Q BioRestorative Therapies For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +1.68% |
Keep exploring
More BRTX: analyst actions → · SEC filings → · BRTX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| PRECISION THERAPEUTICS INC COMMON (AIPT) | 211 | 0.00% | 46% |
| Amarin Corporation plc - American Depositary Shares (AMRN) | 211 | +0.30% | 55% |
| Corvus Pharmaceuticals, Inc. (CRVS) | 208 | -0.32% | 48% |
| Journey Medical Corporation (DERM) | 208 | 0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.